Medy-Tox Inc. (KOSDAQ:086900)
South Korea flag South Korea · Delayed Price · Currency is KRW
141,800
+3,800 (2.75%)
Apr 1, 2025, 3:30 PM KST

Medy-Tox Statistics

Total Valuation

Medy-Tox has a market cap or net worth of KRW 944.31 billion. The enterprise value is 976.82 billion.

Market Cap 944.31B
Enterprise Value 976.82B

Important Dates

The last earnings date was Monday, March 24, 2025.

Earnings Date Mar 24, 2025
Ex-Dividend Date Sep 27, 2024

Share Statistics

Medy-Tox has 6.66 million shares outstanding. The number of shares has decreased by -4.14% in one year.

Current Share Class n/a
Shares Outstanding 6.66M
Shares Change (YoY) -4.14%
Shares Change (QoQ) +0.99%
Owned by Insiders (%) 20.22%
Owned by Institutions (%) 10.39%
Float 4.87M

Valuation Ratios

The trailing PE ratio is 59.66 and the forward PE ratio is 21.15.

PE Ratio 59.66
Forward PE 21.15
PS Ratio 4.42
PB Ratio 2.03
P/TBV Ratio 2.09
P/FCF Ratio 33.93
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.15, with an EV/FCF ratio of 35.10.

EV / Earnings 57.61
EV / Sales 4.27
EV / EBITDA 21.15
EV / EBIT 37.25
EV / FCF 35.10

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.17.

Current Ratio 1.67
Quick Ratio 1.04
Debt / Equity 0.17
Debt / EBITDA 2.02
Debt / FCF 2.92
Interest Coverage 11.78

Financial Efficiency

Return on equity (ROE) is 3.38% and return on invested capital (ROIC) is 2.28%.

Return on Equity (ROE) 3.38%
Return on Assets (ROA) 2.07%
Return on Invested Capital (ROIC) 2.28%
Return on Capital Employed (ROCE) 4.04%
Revenue Per Employee 317.09M
Profits Per Employee 23.52M
Employee Count 721
Asset Turnover 0.37
Inventory Turnover 1.45

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -2.54% in the last 52 weeks. The beta is 0.12, so Medy-Tox's price volatility has been lower than the market average.

Beta (5Y) 0.12
52-Week Price Change -2.54%
50-Day Moving Average 124,894.00
200-Day Moving Average 150,217.00
Relative Strength Index (RSI) 68.25
Average Volume (20 Days) 56,140

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Medy-Tox had revenue of KRW 228.62 billion and earned 16.95 billion in profits. Earnings per share was 2,377.00.

Revenue 228.62B
Gross Profit 138.58B
Operating Income 20.35B
Pretax Income 17.50B
Net Income 16.95B
EBITDA 40.31B
EBIT 20.35B
Earnings Per Share (EPS) 2,377.00
Full Income Statement

Balance Sheet

The company has 59.51 billion in cash and 81.32 billion in debt, giving a net cash position of -21.80 billion or -3,273.96 per share.

Cash & Cash Equivalents 59.51B
Total Debt 81.32B
Net Cash -21.80B
Net Cash Per Share -3,273.96
Equity (Book Value) 476.65B
Book Value Per Share 69,966.38
Working Capital 74.88B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 36.56 billion and capital expenditures -8.73 billion, giving a free cash flow of 27.83 billion.

Operating Cash Flow 36.56B
Capital Expenditures -8.73B
Free Cash Flow 27.83B
FCF Per Share 4,179.07
Full Cash Flow Statement

Margins

Gross margin is 60.62%, with operating and profit margins of 8.90% and 7.42%.

Gross Margin 60.62%
Operating Margin 8.90%
Pretax Margin 7.65%
Profit Margin 7.42%
EBITDA Margin 17.63%
EBIT Margin 8.90%
FCF Margin 12.17%

Dividends & Yields

This stock pays an annual dividend of 1,100.00, which amounts to a dividend yield of 0.80%.

Dividend Per Share 1,100.00
Dividend Yield 0.80%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 49.69%
Buyback Yield 4.14%
Shareholder Yield 4.94%
Earnings Yield 1.80%
FCF Yield 2.95%
Dividend Details

Stock Splits

The last stock split was on December 28, 2022. It was a forward split with a ratio of 1.05.

Last Split Date Dec 28, 2022
Split Type Forward
Split Ratio 1.05

Scores

Medy-Tox has an Altman Z-Score of 6.31.

Altman Z-Score 6.31
Piotroski F-Score n/a